Conference | Session 1: Connectivity and Patient-centricity (Connectivité et centricité du patient)

• The role of devices in VAMs: Evolution of devices, how companies think of devices now, patient centricity and good product design
• Therapy areas with unmet needs: Which therapy areas lend themselves naturally to disruption from devices
• What does a digital strategy look like? How companies, from innovators to generics can implement an effective digital strategy
• Beyond digital: influencing patient behaviour: What is on the horizon? Gamification as an important element in providing value
 

There are many benefits to the introduction of active and intelligent features to packaging. There is a multitude of technologies available from printed codes through embedded and integrated flexible electronics to complex conventional electronic solutions. We will give an overview of the different drivers for active and intelligent packaging in pharma and will link these to the appropriate potential technological solutions highlighting the factors needed in the decision making process. We will give examples of where printed or flexible hybrid electronics provide the unique features required for the intended use and will describe what can be achieved with this emerging technology. We will show why now is the time for smart packaging to shine and how together we can develop an intelligent packaging ecosystem of the future.

We have heard much about the need for, and advantages of, connected medical devices. In this presentation, we shall cover the main risks and strategies to manage those risks using real-world case studies where possible. The types of risks and strategies that we shall cover include:
• Technical (examples include robustness, complexity, security, data breaches)
• Usability (human factors)
• Supply chain
• Business model
• Regulatory and legal